Back

Very long-term follow-up of pulmonary vein isolation using cryoballoon for catheter ablation for atrial fibrillation

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation catheter ablation outcome (1) Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Marco Schiavone

Monzino Cardiology Centre, Milan (Italy)

6 More presentations in this session

Presentation thumbnail
Left atrial appendage flow and recurrences of atrial fibrillation after catheter ablation.
Doctor M. Negreira-Caamano (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
The effects of early recurrence of atrial fibrillation on left atrial remodeling after pulmonary vein isolation - A cardiac magnetic resonance study.
Ms N. Van Pouderoijen (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Outcomes of atrial fibrillation ablation in patients with chronic kidney disease
Doctor A. Abbo (Haifa, IL)
Abstract Slides Video
Presentation thumbnail
Impact on ganglionated plexi and arrhythmia recurrence of pulmonary vein isolation with pulsed field ablation compared to thermal energy
Doctor A. Del Monte (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Early recurrence of atrial arrhythmia and healthcare utilization during the 8-week blanking period following catheter ablation of atrial fibrillation
Doctor A. Benz (Hamilton, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation catheter ablation outcome (1)

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Anticoagulation guided by long-term ECG monitoring in patients who remain free of atrial fibrillation for the first year following pulmonary vein isolation
thumbnail
Congress Presentation
Impact of early atrial arrhythmia recurrence on long-term CryoPVI success
thumbnail
Congress Presentation
Impact of pulmonary vein variant anatomy during cryo-ablation in paroxysmal and persistent AF patients: 1-year outcome from a nationwide multicenter clinical setting

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources